MUFG Americas’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-38,085
| Closed | -$17.3M | – | 236 |
|
|
2022
Q3 | $17.3M | Buy |
38,085
+1,797
| +5% | +$860K | 0.43% | 68 |
|
|
2022
Q2 | $17.5M | Sell |
36,288
-362
| -1% | -$179K | 0.4% | 74 |
|
|
2022
Q1 | $18M | Buy |
36,650
+7,923
| +28% | +$3.62M | 0.35% | 78 |
|
|
2021
Q4 | $13.3M | Sell |
28,727
-7,408
| -21% | -$3.12M | 0.25% | 109 |
|
|
2021
Q3 | $13.5M | Buy |
36,135
+769
| +2% | +$292K | 0.24% | 102 |
|
|
2021
Q2 | $13.5M | Buy |
35,366
+1,732
| +5% | +$662K | 0.22% | 104 |
|
|
2021
Q1 | $12.1M | Buy |
33,634
+1,346
| +4% | +$433K | 0.21% | 110 |
|
|
2020
Q4 | $10.4M | Buy |
32,288
+2,436
| +8% | +$748K | 0.18% | 121 |
|
|
2020
Q3 | $8.02M | Buy |
29,852
+2,167
| +8% | +$583K | 0.21% | 116 |
|
|
2020
Q2 | $7.28M | Buy |
27,685
+2,449
| +10% | +$653K | 0.21% | 123 |
|
|
2020
Q1 | $5.73M | Buy |
25,236
+3,071
| +14% | +$837K | 0.19% | 128 |
|
|
2019
Q4 | $6.7M | Buy |
22,165
+1,792
| +9% | +$493K | 0.17% | 141 |
|
|
2019
Q3 | $4.89M | Buy |
20,373
+721
| +4% | +$198K | 0.14% | 158 |
|
|
2019
Q2 | $5.54M | Buy |
19,652
+3,687
| +23% | +$1.01M | 0.16% | 153 |
|
|
2019
Q1 | $4.58M | Buy |
15,965
+6,175
| +63% | +$1.79M | 0.13% | 166 |
|
|
2018
Q4 | $2.57M | Buy |
9,790
+3,456
| +55% | +$950K | 0.08% | 191 |
|
|
2018
Q3 | $1.74M | Buy |
6,334
+4,148
| +190% | +$1.08M | 0.05% | 229 |
|
|
2018
Q2 | $520K | Buy |
2,186
+490
| +29% | +$113K | 0.02% | 310 |
|
|
2018
Q1 | $373K | Sell |
1,696
-31
| -2% | -$7.28K | 0.01% | 345 |
|
|
2017
Q4 | $389K | Sell |
1,727
-3
| -0.2% | -$639 | 0.01% | 359 |
|
|
2017
Q3 | $328K | Sell |
1,730
-2,166
| -56% | -$412K | 0.01% | 386 |
|
|
2017
Q2 | $733K | Sell |
3,896
-4,174
| -52% | -$750K | 0.02% | 315 |
|
|
2017
Q1 | $1.33M | Buy |
8,070
+5,818
| +258% | +$925K | 0.04% | 250 |
|
|
2016
Q4 | $324K | Buy |
2,252
+153
| +7% | +$20.5K | 0.01% | 397 |
|
|
2016
Q3 | $263K | Sell |
2,099
-138
| -6% | -$17.8K | 0.01% | 429 |
|
|
2016
Q2 | $294K | Sell |
2,237
-1,340
| -37% | -$183K | 0.01% | 398 |
|
|
2016
Q1 | $497K | Sell |
3,577
-150
| -4% | -$20K | 0.02% | 337 |
|
|
2015
Q4 | $520K | Sell |
3,727
-830
| -18% | -$114K | 0.02% | 336 |
|
|
2015
Q3 | $638K | Sell |
4,557
-412
| -8% | -$61.9K | 0.02% | 332 |
|
|
2015
Q2 | $816K | Buy |
4,969
+225
| +5% | +$35.9K | 0.03% | 312 |
|
|
2015
Q1 | $733K | Sell |
4,744
-5
| -0.1% | -$712 | 0.02% | 325 |
|
|
2014
Q4 | $597K | Sell |
4,749
-481
| -9% | -$59.4K | 0.02% | 357 |
|
|
2014
Q3 | $626K | Sell |
5,230
-1,524
| -23% | -$175K | 0.02% | 342 |
|
|
2014
Q2 | $726K | Sell |
6,754
-10,229
| -60% | -$1.05M | 0.02% | 340 |
|
|
2014
Q1 | $1.69M | Buy |
16,983
+5,957
| +54% | +$539K | 0.06% | 227 |
|
|
2013
Q4 | $1.02M | Sell |
11,026
-925
| -8% | -$82.2K | 0.03% | 282 |
|
|
2013
Q3 | $999K | Sell |
11,951
-5,621
| -32% | -$482K | 0.03% | 294 |
|
|
2013
Q2 | $1.44M | Buy |
+17,572
| New | +$1.32M | 0.03% | 450 |
|
Other funds holding ELV
MUFG Americas's ELV Position: Q4 2022 in Review
MUFG Americas sold out of Elevance Health (ELV) in Q4 2022, closing a stake of 38,085 shares — an estimated $17.3M sold.
MUFG Americas first reported a position in ELV in Q2 2013 and held it in 38 quarters. The position peaked at $18M in Q1 2022. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.
- MUFG Americas reported no remaining Elevance Health position as of Q4 2022 after selling out during the quarter.
- MUFG Americas sold 38,085 Elevance Health shares in Q4 2022, an estimated $17.3M.
- MUFG Americas first reported a position in Elevance Health in Q2 2013 and held it in 38 quarters.
- MUFG Americas's Elevance Health position peaked at $18M in Q1 2022.
- 1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.
Based on MUFG Americas's 13F filing for Q4 2022.